Cost-effectiveness analysis of using hypoxic stored red blood cells to reduce the frequency of blood transfusions

Previous PostTreatment adherence and quality of life in UK distal renal tubular acidosis patients
Next PostIs EU orphan medicine status working? A retrospective analysis of orphan drug reimbursement in England